Valneva SE (VALN) EPS (Diluted) (QoQ) (2021 - 2026)
Valneva SE (VALN) EPS (Diluted) (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.68% |
| Dec 31, 2025 | 10.30% |
| Sep 30, 2025 | -344.99% |
| Jun 30, 2025 | -82.38% |
| Mar 31, 2025 | 47.58% |
| Dec 31, 2024 | 50.75% |
| Sep 30, 2024 | -1.94% |
| Jun 30, 2024 | -131.59% |
| Mar 31, 2024 | 373.85% |
| Dec 31, 2023 | 6.60% |
| Sep 30, 2023 | -20.78% |
| Jun 30, 2023 | -10.97% |
| Mar 31, 2023 | 70.59% |
| Dec 31, 2022 | -151.05% |
| Sep 30, 2022 | 165.76% |
| Jun 30, 2022 | -466.82% |
| Mar 31, 2022 | -114.80% |
| Dec 31, 2021 | 199.84% |
| Sep 30, 2021 | -178.29% |
| Jun 30, 2021 | -99.11% |